Dr Reddy’s Laboratories share price ends nearly flat at ₹1,310 on October 27

Key Takeaways

• Dr Reddy’s Laboratories ended at ₹1,310, down just ₹0.90 or 0.07%, after trading between ₹1,299 and ₹1,324.
• The close remained above the 50-day DMA of ₹1,211.80, 100-day DMA of ₹1,219.30 and 200-day DMA of ₹1,233.40.
• The three-month return stood at 13.74%, while six-month performance was slightly negative at -0.54%.

Dr Reddy’s Laboratories share price closed October 27 at ₹1,310, slipping ₹0.90 or 0.07%. The stock opened at ₹1,309 against the previous close of ₹1,311. During the session it reached ₹1,324 at the high and ₹1,299 at the low, a ₹25 span. The final price was ₹11 above the low and ₹14 below the high, placing it close to the centre of the day's range. It also finished ₹1 above the opening price despite the marginal decline from the previous close.

Volume reached 2,273,498 shares. Unlike several Nifty 50 constituents in the session, Dr Reddy’s closed above all three displayed moving averages. The 50-day DMA was ₹1,211.80, leaving the final price ₹98.20 higher. The 100-day DMA stood at ₹1,219.30, a ₹90.70 difference, while the 200-day DMA of ₹1,233.40 was ₹76.60 below the close.

The stock's 52-week range extended from ₹1,101 to ₹1,415. At ₹1,310, the October 27 close was ₹209 above the annual low and ₹105 below the annual high. That placed the stock considerably closer to its 52-week high in rupee terms.

The return profile was mixed but stronger over the shorter periods. One-month performance stood at 9.08%, while the three-month return reached 13.74%. The six-month figure was slightly negative at -0.54%, and the one-year return was 2.06%. The gap between the three-month and six-month readings was 14.28 percentage points.

The day's 0.07% decline was therefore small compared with the movement visible in the return periods and intraday range. Dr Reddy’s finished almost unchanged from the previous close, above all three moving averages and ₹105 below its 52-week high.